RxDoctor Payments Data

Alison Emmons

Nurse Practitioner · Hilliard, OHNPI 1144917527

Payments from drug & device makers

$725in general payments, 2019–2025

Across 31 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$205
  • Spinal Simplicity, LLC$156
  • Lilly USA, LLC$135
  • Novo Nordisk$100
  • Exact Sciences$50
  • AstraZeneca$44
  • plus $36 from 2 others

What the payments were for

  • Food & beverage$725100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$725 in reported general payments places this provider in the 80th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$38,926
Medicare patients
205
Services billed
902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$17,744
Venlafaxine Hcl ErVenlafaxine Hcl22$1,698
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$1,432
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf11$808
Atorvastatin Calcium76$733
Albuterol Sulfate HfaAlbuterol Sulfate36$710
Gabapentin36$671
Losartan Potassium52$654
Pantoprazole Sodium51$609
Omeprazole52$565
Amlodipine Besylate72$509
Levothyroxine Sodium49$416
Rosuvastatin Calcium27$307
Fluticasone Propionate11$306
Tizanidine Hcl18$289

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$100$17,74417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Hilliard

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →